Akari Therapeutics, Plc (AKTX)

NASDAQ: AKTX · Real-Time Price · USD

1.270

-0.030 (-2.31%)

At close: Mar 28, 2025, 4:00 PM

1.250

-0.020 (-1.57%)

After-hours: Mar 28, 2025, 4:04 PM EDT

Akari Therapeutics, Stock Forecast

Stock Price Forecast

There is currently no analyst price target forecast available for Akari Therapeutics,.

Analyst Consensus: n/a

Target	Low	Average	Median	High
Price	n/a	n/a	n/a	n/a
Change	n/a	n/a	n/a	n/a

Analyst Ratings

There are currently no analyst ratings available for Akari Therapeutics,.

Recommendation Trends

Rating	Jul '22	Aug '22	Sep '22	Oct '22	Nov '22
Strong Buy	1	1	1	1	1
Buy	0	0	0	0	0
Hold	0	0	0	0	0
Sell	0	0	0	0	0
Strong Sell	0	0	0	0	0
Total	1	1	1	1	1

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Sean Lee HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Initiates $30	Strong Buy	Initiates	$30	+2,262.20%	Dec 5, 2022
James Molloy Alliance Global Partners	Alliance Global Partners	Strong Buy Initiates $80	Strong Buy	Initiates	$80	+6,199.21%	Nov 1, 2022
Madhu Kumar B. Riley Securities	B. Riley Securities	Strong Buy Maintains $140 → $100	Strong Buy	Maintains	$140 → $100	+7,774.02%	Mar 13, 2020
Arlinda Lee Canaccord Genuity	Canaccord Genuity	Strong Buy Maintains $300 → $160	Strong Buy	Maintains	$300 → $160	+12,498.43%	Mar 29, 2018
Madhu Kumar B. Riley Securities	B. Riley Securities	Hold Initiates $60	Hold	Initiates	$60	+4,624.41%	Feb 8, 2018

More Analyst Ratings

Financial Forecast

Revenue This Year

n/a

Revenue Next Year

n/a

EPS This Year

-3.47

from -2.04

EPS Next Year

-3.67

from -3.47

Fiscal Year	FY 2019	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025
Period Ending	Dec 31, 2019	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025
Revenue	-	4.28M
Revenue Growth	-	-	-	-	-	-	-
EPS	-18.40	-20.00	-8.12	-5.69	-2.04	-3.47	-3.67
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	3	3

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2024	2025
High	n/a	4.4M
Avg	n/a	4.3M
Low	n/a	4.1M

Revenue Growth

Revenue Growth	2024	2025
High	-	-
Avg	-	-
Low	-	-

EPS Forecast

EPS	2024	2025
High	-3.57	-3.78
Avg	-3.47	-3.67
Low	-3.33	-3.53

EPS Growth

EPS Growth	2024	2025
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.